5,N-dimethyl-N-isopropyltryptamine
From Wikipedia, the free encyclopedia
|
5,N-dimethyl-N-isopropyltryptamine
|
|
| Systematic (IUPAC) name | |
| isopropyl-(2-(1H-indol-3-yl)-ethyl)-methylamine | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C15H22N2 |
| Mol. mass | 230.36 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
5,N-dimethyl-N-isopropyltryptamine (5-Me-MIPT) is a tryptamine derivative that is thought to be a hallucinogenic drug. It was first made in 1989. In vitro binding experiments on brain homogenates showed it to have a binding affinity between that of MIPT and 5-MeO-MIPT, [1] both of which are known to be active hallucinogens in humans.
[edit] References
- ^ McKenna DJ, Repke DB, Peroutka SJ Neuropharmacology 29:193-198 (1989)
|
|||||

